Literature DB >> 16545334

De novo proteomic sequencing of a monoclonal antibody raised against OX40 ligand.

Victoria Pham1, William J Henzel, David Arnott, Sarah Hymowitz, Wendy N Sandoval, Bao-Tran Truong, Henry Lowman, Jennie R Lill.   

Abstract

De novo sequencing of a full-length monoclonal antibody raised against OX40 ligand is described. Using a combination of overlapping complementary proteolytic and chemical digestions, with analysis by mass spectrometry and Edman degradation, both the heavy and light chains were fully sequenced. Particular attention was paid to those modifications that could be susceptible to degradation in the complementarity determining region and Fc region. An overview of the protocol is described, and suggestions for improvements to aid in such sequencing projects in the future are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545334     DOI: 10.1016/j.ab.2006.02.001

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies.

Authors:  Keith W Rickert; Luba Grinberg; Robert M Woods; Susan Wilson; Michael A Bowen; Manuel Baca
Journal:  MAbs       Date:  2016       Impact factor: 5.857

2.  Determination of primary structure and microheterogeneity of a beta-amyloid plaque-specific antibody using high-performance LC-tandem mass spectrometry.

Authors:  Irina Perdivara; Leesa Deterding; Adrian Moise; Kenneth B Tomer; Michael Przybylski
Journal:  Anal Bioanal Chem       Date:  2008-03-28       Impact factor: 4.142

3.  A quantitative tool to distinguish isobaric leucine and isoleucine residues for mass spectrometry-based de novo monoclonal antibody sequencing.

Authors:  Chloe N Poston; Richard E Higgs; Jinsam You; Valentina Gelfanova; John E Hale; Michael D Knierman; Robert Siegel; Jesus A Gutierrez
Journal:  J Am Soc Mass Spectrom       Date:  2014-05-21       Impact factor: 3.109

Review 4.  The spectral networks paradigm in high throughput mass spectrometry.

Authors:  Adrian Guthals; Jeramie D Watrous; Pieter C Dorrestein; Nuno Bandeira
Journal:  Mol Biosyst       Date:  2012-10

5.  Resurrection of a clinical antibody: template proteogenomic de novo proteomic sequencing and reverse engineering of an anti-lymphotoxin-α antibody.

Authors:  Natalie E Castellana; Krista McCutcheon; Victoria C Pham; Kristin Harden; Allen Nguyen; Judy Young; Camellia Adams; Kurt Schroeder; David Arnott; Vineet Bafna; Jane L Grogan; Jennie R Lill
Journal:  Proteomics       Date:  2011-01-05       Impact factor: 3.984

6.  Automated Antibody De Novo Sequencing and Its Utility in Biopharmaceutical Discovery.

Authors:  K Ilker Sen; Wilfred H Tang; Shruti Nayak; Yong J Kil; Marshall Bern; Berk Ozoglu; Beatrix Ueberheide; Darryl Davis; Christopher Becker
Journal:  J Am Soc Mass Spectrom       Date:  2017-01-19       Impact factor: 3.109

7.  Two-dimensional southwestern blotting and characterization of transcription factors on-blot.

Authors:  Daifeng Jiang; Yinshan Jia; YanWen Zhou; Harry W Jarrett
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

8.  Automated de novo protein sequencing of monoclonal antibodies.

Authors:  Nuno Bandeira; Victoria Pham; Pavel Pevzner; David Arnott; Jennie R Lill
Journal:  Nat Biotechnol       Date:  2008-12       Impact factor: 54.908

9.  An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions.

Authors:  Lennard J M Dekker; Lona Zeneyedpour; Eric Brouwer; Martijn M van Duijn; Peter A E Sillevis Smitt; Theo M Luider
Journal:  Anal Bioanal Chem       Date:  2010-11-24       Impact factor: 4.142

10.  Multi-spectra peptide sequencing and its applications to multistage mass spectrometry.

Authors:  Nuno Bandeira; Jesper V Olsen; Jesper V Mann; Matthias Mann; Pavel A Pevzner
Journal:  Bioinformatics       Date:  2008-07-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.